Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ketorolac Trometamol
Therapeutic Area : Ophthalmology
Study Phase : Approved
Sponsor : Ache Laboratorios Farmaceuticos SA
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Nemera's multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON (Ketorolac 0,4% and 0,5%), a nonsteroidal anti-inflammatory drug that is used to treat moderately severe pain and inflammation, usually aft...
Brand Name : Clilon
Molecule Type : Small molecule
Upfront Cash : Not Applicable
May 06, 2021
Lead Product(s) : Ketorolac Trometamol
Therapeutic Area : Ophthalmology
Highest Development Status : Approved
Sponsor : Ache Laboratorios Farmaceuticos SA
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?